Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the TONADO(®) Trials

INTRODUCTION: Since chronic obstructive pulmonary disease (COPD) is a heterogeneous condition, a composite endpoint of clinically important deterioration (CID) may provide a more holistic assessment of treatment efficacy. We compared long-acting muscarinic antagonist/long-acting β(2)-agonist combina...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabe, Klaus F., Chalmers, James D., Miravitlles, Marc, Kocks, Janwillem W. H., Tsiligianni, Ioanna, de la Hoz, Alberto, Xue, Wenqiong, Singh, Dave, Ferguson, Gary T., Wedzicha, Jadwiga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854451/
https://www.ncbi.nlm.nih.gov/pubmed/33175291
http://dx.doi.org/10.1007/s12325-020-01528-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854451/
https://www.ncbi.nlm.nih.gov/pubmed/33175291
http://dx.doi.org/10.1007/s12325-020-01528-2

Ejemplares similares